International cohort of 382 children with lupus nephritis – presentation, treatment and outcome at 24 months.

Background: Children with lupus have a higher chance of nephritis and worse kidney outcome than adult patients. Methods: We retrospectively analyzed clinical presentation, treatment and 24-month kidney outcome in a cohort of 382 patients (≤ 18 years old) with lupus nephritis (LN) class ≥ III diagnos...

Descripción completa

Detalles Bibliográficos
Publicado en:Pediatric Nephrology Vol. 38; no. 11; pp. 3699 - 3710
Autores principales: De Mutiis, Chiara, Wenderfer, Scott E., Basu, Biswanath, Bagga, Arvind, Orjuela, Alvaro, Sar, Tanmoy, Aggarwal, Amita, Jain, Avinash, Yap, Hui-Kim, Teo, Sharon, Ito, Shuichi, Ohnishi, Ai, Iwata, Naomi, Kasapcopur, Ozgur, Yildiz, Mehmet, Laurent, Audrey, Mastrangelo, Antonio, Ogura, Masao, Shima, Yuko, Rianthavorn, Pornpimol
Formato: research tables/charts Journal Article
Publicado: Springer Nature Nov2023
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=172285021&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 172285021
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        0931041X
        EF1
      jtl: Pediatric Nephrology
      issn: 0931041X
      maglogo: N
    pubinfo:
      dt: Nov2023
      vid: 38
      iid: 11
      pid: 237
      pub: Springer Nature
      place: New York, New York
    artinfo:
      ui:
        172285021
        163865054
        172285021
        172285021
        10.1007/s00467-023-06018-5
        172285021
      ppf: 3699
      ppct: 11
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: International cohort of 382 children with lupus nephritis – presentation, treatment and outcome at 24 months.
      aug:
        au:
          De Mutiis, Chiara
          Wenderfer, Scott E.
          Basu, Biswanath
          Bagga, Arvind
          Orjuela, Alvaro
          Sar, Tanmoy
          Aggarwal, Amita
          Jain, Avinash
          Yap, Hui-Kim
          Teo, Sharon
          Ito, Shuichi
          Ohnishi, Ai
          Iwata, Naomi
          Kasapcopur, Ozgur
          Yildiz, Mehmet
          Laurent, Audrey
          Mastrangelo, Antonio
          Ogura, Masao
          Shima, Yuko
          Rianthavorn, Pornpimol
        affil: Paediatric Unit, Maggiore Hospital, Azienda USL, Bologna, Italy
      sug:
        subj:
          Lupus Nephritis Symptoms
          Lupus Nephritis Therapy
          Treatment Outcomes
          Human
          Retrospective Design
          Record Review
          Child
          Age of Onset
          Male
          Female
          Disease Remission
          Age Factors
          Descriptive Statistics
          Lupus Nephritis Diagnosis
          Kidney Physiology
          Child: 6-12 years
          Male
          Female
      ab: Background: Children with lupus have a higher chance of nephritis and worse kidney outcome than adult patients. Methods: We retrospectively analyzed clinical presentation, treatment and 24-month kidney outcome in a cohort of 382 patients (≤ 18 years old) with lupus nephritis (LN) class ≥ III diagnosed and treated in the last 10 years in 23 international centers. Results: The mean age at onset was 11 years 9 months and 72.8% were females. Fifty-seven percent and 34% achieved complete and partial remission at 24-month follow-up, respectively. Patients with LN class III achieved complete remission more often than those with classes IV or V (mixed and pure). Only 89 of 351 patients maintained stable complete kidney remission from the 6th to 24th months of follow-up. eGFR ≥ 90 ml/min/1.73 m2 at diagnosis and biopsy class III were predictive of stable kidney remission. The youngest and the oldest age quartiles (2y—9y, 5m) (14y, 2m—18y,2m) showed lower rates of stable remission (17% and 20.7%, respectively) compared to the two other age groups (29.9% and 33.7%), while there was no difference in gender. No difference in achieving stable remission was found between children who received mycophenolate or cyclophosphamide as induction treatment. Conclusion: Our data show that the rate of complete remission in patients with LN is still not high enough. Severe kidney involvement at diagnosis was the most important risk factor for not achieving stable remission while different induction treatments did not impact outcome. Randomized treatment trials involving children and adolescents with LN are needed to improve outcome for these children.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N